Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 1

Interventions

Magnetic Resonance Spectroscopy 7 X-Rays 5 Specimen Handling 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Temozolomide 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 olaparib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Vincristine 2 Cyclophosphamide 2 Cisplatin 2 tazemetostat 1 pembrolizumab 1 palbociclib 1 lutetium Lu 177 dotatate 1 Vemurafenib 1 Vascular Endothelial Growth Factor A 1 Triiodothyronine 1 Thiotepa 1 Radiotherapy 1 Radiation 1 Platinum 1 Pharmacogenomic Variants 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Medulloblastoma × Vascular Endothelial Growth Factor A × 30 days × Clear all

NCT07346157 2026-06-01

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡